Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LEXX is expected to report earnings to fall 7.69% to -11 cents per share on April 14
Q1'26
Est.
$-0.12
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.02
Q2'25
Missed
by $0.05
Q1'25
Est.
$-0.17
The last earnings report on January 21 showed earnings per share of -12 cents, beating the estimate of -17 cents. With 107.89K shares outstanding, the current market capitalization sits at 19.06M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LEXX showed earnings on January 21, 2026. You can read more about the earnings report here.